 |
 |
|
|
|
| Thymosin β4 Acetate |
 |
| C212H350N56O78S |
 |
| 75591-33-4(net) |
 |
| It is expected to clinically heal the wound and inhibit the scar, etc. |
 |
Parameters of Product:
1.Purity (HPLC)
95%min.
2.Appearance White powder
3.Single Impurity (HPLC) 2.0%max
4.Amino Acid Composition ±10% of theoretical
5.Peptide Content (N%) ≥80.0%
6.WaterContent(Karl Fischer) ≤5.0%
7.Acetate Content (HPIC) ≤15.0%
8.MS(ESI)
Consistent
9.Mass Balance 95.0~105.0%
|
|
|
|
|
|
